科妍

+0.55 (+1.29%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

43.30215成交張數17.75本益比1.77股價淨值比4.41%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度	單季 EPS	年增	近四季 EPS	歸屬母公司淨利(億)	淨利率	ROE(季)	ROE(近四季)
2026Q2	0.47	–	2.43	0.35	16.4%	1.90%	10.16%
2026Q1	0.29	-63.3%	1.74	0.22	10.7%	1.14%	7.09%
2025Q4	0.86	-7.5%	2.24	0.63	25.1%	3.24%	8.37%
2025Q3	0.81	-1.2%	2.31	0.58	26.3%	3.20%	8.80%
2025Q2	-0.22	-122.0%	2.32	-0.16	-7.6%	-0.93%	9.57%
2025Q1	0.79	4.0%	3.54	0.57	27.8%	3.13%	15.13%
2024Q4	0.93	60.3%	3.51	0.66	25.7%	3.52%	13.75%
2024Q3	0.82	0.0%	3.16	0.57	25.7%	3.25%	12.67%
2024Q2	1.00	31.6%	3.16	0.68	32.2%	4.20%	13.31%
2024Q1	0.76	52.0%	2.92	0.52	26.5%	3.27%	12.64%
2023Q4	0.58	28.9%	2.66	0.39	19.4%	2.45%	11.34%
2023Q3	0.82	20.6%	2.53	0.55	26.5%	3.53%	11.01%
2023Q2	0.76	26.7%	2.39	0.51	27.9%	3.31%	10.84%
2023Q1	0.50	21.9%	2.23	0.33	27.2%	2.12%	9.65%
2022Q4	0.45	15.4%	2.14	0.30	18.5%	1.98%	9.57%
2022Q3	0.68	125.1%	2.08	0.46	27.6%	3.15%	9.52%
2022Q2	0.60	25.2%	1.70	0.40	30.0%	2.74%	7.77%
2022Q1	0.41	11.2%	1.58	0.27	26.9%	1.84%	7.16%
2021Q4	0.39	-27.0%	1.54	0.25	18.1%	1.77%	7.13%
2021Q3	0.30	-41.3%	1.68	0.20	15.8%	1.39%	7.99%
2021Q2	0.48	43.7%	1.90	0.32	24.9%	2.19%	8.97%
2021Q1	0.37	-33.3%	1.75	0.25	22.1%	1.74%	8.23%
2020Q4	0.53	-11.7%	1.94	0.35	26.8%	2.54%	9.26%
2020Q3	0.51	30.3%	2.01	0.34	28.1%	2.51%	9.84%
2020Q2	0.33	-9.5%	1.89	0.22	21.5%	1.64%	9.43%
2020Q1	0.55	18.9%	1.92	0.36	33.1%	2.63%	9.22%
2019Q4	0.61	9.9%	1.83	0.40	30.7%	2.97%	9.90%
2019Q3	0.40	54.1%	1.78	0.26	25.0%	1.96%	9.48%
2019Q2	0.37	516.4%	1.64	0.25	25.2%	1.91%	9.19%
2019Q1	0.47	-21.1%	1.33	0.30	28.5%	2.44%	7.01%
2018Q4	0.55	89.7%	1.46	0.32	31.0%	2.96%	8.72%
2018Q3	0.26	2881.4%	1.20	0.16	22.1%	1.62%	7.50%
2018Q2	0.06	249.7%	0.95	0.04	7.2%	0.38%	6.27%
2018Q1	0.59	–	0.91	0.36	34.2%	3.82%	5.96%
2017Q4	0.29	-19.1%	0.28	0.18	20.3%	1.94%	1.90%
2017Q3	0.01	–	0.35	0.01	1.5%	0.09%	2.39%
2017Q2	0.02	101.2%	-0.45	0.01	1.3%	0.10%	-3.04%
2017Q1	-0.03	–	-0.46	-0.02	-4.3%	-0.24%	-3.03%
2016Q4	0.36	–	-0.44	0.22	29.9%	2.43%	–
2016Q3	-0.79	–	–	-0.48	-78.3%	-5.33%	–